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Background/Aims
The diagnosis of functional heartburn is important for management, however it stands on fragile pH monitoring variables, ie, 
acid exposure time varies from day to day and symptoms are often few or absent. Aim of this study was to investigate con-
sistency of the diagnosis of functional heartburn in subsequent days using prolonged wireless pH monitoring and its impact 
on patients’ outcome.
Methods
Fifty proton pump inhibitotor refractory patients (11 male, 48 years [range, 38-57 years]) with a diagnosis of functional heart-
burn according to Rome III in the first 24 hours of wireless pH monitoring were reviewed. pH variables were analysed in the 
following 24-hour periods to determine if tracings were indicative of diagnosis of non-erosive reflux disease (either acid ex-
posure time ＞ 5% or normal acid exposure time and symptom index ≥ 50%). Outcome was assessed by review of hospital 
files and/or telephone interview.
Results
Fifteen out of 50 patients had a pathological acid exposure time after the first day of monitoring (10 in the second day and 
5 in subsequent days), which changed their diagnosis from functional heartburn to non-erosive reflux disease. Fifty-four percent 
of non-erosive reflux disease vs 11% of functional heartburn patients (P ＜ 0.003) increased the dose of proton pump in-
hibitors or underwent fundoplication after the pH test. Outcome was positive in 77% of non-erosive reflux disease vs 43% of 
functional heartburn patients (P ＜ 0.05).
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Conclusions
One-third of patients classified as functional heartburn at 24-hour pH-monitoring can be re-classified as non-erosive reflux dis-
ease after a more prolonged pH recording period. This observation has a positive impact on patients’ management.
(J Neurogastroenterol Motil 2015;21:265-272)
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Introduction
Heartburn is a common symptom experienced by the general 
population and it is highly suggestive for gastroesophageal reflux 
disease (GERD).1-3 Non-erosive reflux disease (NERD) is the 
most common presentation of this illness, affecting up to 70% of 
individuals.4,5 Patients with heartburn are a heterogeneous group 
including various subpopulations with different mechanisms re-
sponsible for their symptom, ie, patients with typical GERD 
symptoms and either increased esophageal acid exposure or acid 
hypersensitivity, and patients with functional heartburn (FH).6 
The distinction between patients with GERD related and those 
with GERD unrelated heartburn (ie, FH), is clinically highly 
relevant because the first group benefits from pharmacological or 
surgical anti-reflux therapy, whereas the second one should not 
receive prolonged unnecessary proton pump inhibitor (PPI) 
treatment and, even less, antireflux surgery. 
Twenty-four hour esophageal pH-monitoring has long been 
considered the best examination in order to differentiate the vari-
ous types of heartburn patients because it can establish the 
amount of esophageal acid exposure and the correlation between 
reflux and symptoms.7,8 More recently addition of impedance to 
measurement of pH has enabled detection of patients with heart-
burn related to non-acid reflux and their separation from those 
having FH.9 So far studies on pathophysiological differences be-
tween patients with FH and those with NERD, for example in-
tercellular space diameter or histopathological findings, basal im-
pedance, acid sensitivity, somatisation, have relied on 24-hour 
pH or pH and impedance monitoring.10-14
However 24-hour reflux tests have some intrinsic limitation: 
previous studies have shown that esophageal acid exposure time 
(AET) presents a physiological day to day variability due to dif-
ferent dietary habits and physical activity among days;15-17 symp-
toms during single day monitoring are often absent or few, mak-
ing either symptoms reflux association indexes unreliable or im-
possible to be evaluated; finally, patients are often uncomfortable 
and adopt a more sedentary life style, resulting in reduction of re-
flux-provoking activities,18,19 which may further impair the diag-
nostic yield of catheter based studies. These limitations could be 
particularly relevant to patients with NERD who often have nor-
mal acid exposure during 24 pH-monitoring, differently from 
patients with esophagitis who generally have increased reflux20 
and could have biased results of studies aimed at investigating 
differences between FH and NERD. 
The Bravo wireless technique has been developed in order to 
overcome limitations of the traditional catheter-based pH testing. 
This well-known system uses a pH capsule fixed to the esoph-
ageal mucosa that transmits data to a portable receiver using 
radiotelemetry.21 The wireless test is better tolerated compared 
with the catheter based one,22-25 usually lasts 48 horrs and can be 
extended further, increasing its ability to record pathological re-
flux and/or establish symptoms/reflux association.26-29 As a mat-
ter of fact prolonged wireless pH-monitoring has been shown to 
diagnose GERD in patients with a previously negative 24-hour 
catheter based monitoring.30 
Aim of our study was, therefore, to investigate consistency of 
the diagnosis of FH after the first day of pH recording using 
48-96 hours wireless pH monitoring and impact of prolonged 
pH monitoring on outcome.
Materials and Methods
Study Patients
Fifty consecutive PPI refractory patients (11 male, 48 years 
[range, 38-57 years]) with heartburn as dominant complaint and 
a diagnosis of FH according to Rome III,31 ie, no mucosal breaks 
at upper gastrointestinal endoscopy, normal AET (＜ 5% of time 
at pH ＜ 4),16 and symptom index (SI) ＜ 50% in the first 24 
hours of wireless pH monitoring, were retrospectively analysed as 
part of an international collaborative study (Brazil [n = 12], 
Italy [n = 15], and UK [n = 23]). As there are different defi-
nitions for refractoriness to PPIs we have chosen the most in-
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clusive one by considering all patients that were refractory to a 
stable single or double dose PPI treatment. Patients with no 
available data about PPI response were not included in the study. 
Antisecretory drugs (PPI) were stopped at least 8 days before pH 
monitoring; patients were instructed not to use antacid for-
mulations during the whole recordings. Informed written consent 
was obtained from each patient.
Forty-eight to 96-hour Wireless pH 
Monitoring
After external calibration in buffer solutions pH 1.0 and 7.0, 
the Bravo pH capsule (Medtronic Inc, Shoreview, MN, USA) 
was attached 6 cm above the squamocolumnar junction during 
upper endoscopy under mild conscious sedation (1-5 mg mid-
azolam i.v.) as previously described.23 pH monitoring was then 
activated and data were stored into the receiver for 48 hours. 
During the pH study patients were encouraged to engage in their 
usual activities including work, exercise, etc. with the only re-
strictions that no sipping of acidic beverages (eg, orange juice, co-
la) occurred between meals not to alter readings. They were asked 
to press the event marker button on the receiver whenever they 
experienced their symptoms. Furthermore, patients kept diaries 
documenting timing of food intake, change of posture and occur-
rence of symptoms according to their watch, which was synchron-
ized with the Bravo receiver. After 48 hours of pH recording, the 
patients returned to the hospital and gave receivers and diaries 
back. Recorded data were downloaded onto a computer using a 
commercial software (Polygram Net, Medtronic, Denmark), and 
the second 48-hour recording began in 13 and 23 patients of the 
Italian and the British center respectively.
Outcome Evaluation
Patient’s outcome data were obtained by reviewing hospital 
files with regards to consultations occurring after wireless pH 
monitoring and/or by telephone interview with a standardized 
questionnaire.28 Heartburn was classified as same/worse, better 
or absent. Outcome was considered positive if heartburn was bet-
ter or absent. Regarding treatment for GERD, information was 
sought on (1) presence of PPI treatment and whether the PPI 
dose was increased or not compared with pre pH test and (2) oc-
currence of fundoplication.
Statistical Methods
pH variables were analysed in 24-hour periods in order to de-
termine if tracings were indicative of the diagnosis of NERD; ie, 
either AET ＞ 5% or normal AET and SI ≥ 50% for heartburn, 
provided patients had at least 3 heartburn episodes/day; in case 
heartburn episodes/24-hour were less than three, the SI was not 
evaluated and classification of patients as FH or not was based 
solely on AET data. Patients with less than 3 symptomatic epi-
sodes were excluded form SI evaluation because symptom/reflux 
association indexes are known not to be reliable when the number 
of episodes is very low.32 Based on these criteria patients were re-
classified as FH or NERD at the end of the test. Furthermore, 
percentage time at pH ＜ 4 in upright and supine position were 
calculated in tracings of patients who had a change in their diag-
nosis because of increased AET. Only days with at least 21-hour 
recordings were included.
Presence of other esophageal symptoms (acid regurgitation 
and chest pain) was also considered in order to better characterize 
patients. SI was calculated separately for regurgitation and chest 
pain only if at least three episodes/day occurred. Moreover a 
global SI (heartburn, regurgitation, and chest pain) was calcu-
lated for each patient. The number of symptomatic events (both 
heartburn and the other symptoms) for every single 24-hour of 
recording and for the whole monitoring were also collected.
Data were expressed as median (first and third quartile). Non 
parametric statistics and chi-square test were used when appro-
priate. ANOVA followed by Fisher’s test was used to compare 
variability of occurrence of symptoms among the 4 days.
Results
All patients (N = 50) completed at least 48 hours of the pro-
longed wireless pH-study. Out of the 36 patients prolonging 
monitoring beyond 48 hours, capsule detachment occurred be-
tween 48 and 72 hours in 9 patients, and between 72 and 96 hours 
in 12 patients. Thus, 96-hour recordings were available in 15 of 
the 50 patients. All patients reported normal activities of daily liv-
ing during the wireless pH-study. 
Impact of Prolonged pH-monitoring on 
Diagnosis
Gastro-esophageal reflux
Fifteen (3 male, 55 years [range, 46-59 years]) out of the 50 
patients showed a pathological AET after the first 24 hours of 
monitoring (10 in the second day, 2 in the third day, and 3 in the 
last day of recording), which changed their diagnosis from FH to 
NERD, whereas in the remaining 35 the diagnosis of FH was 
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Figure. Daily acid exposure time, expressed as % time at pH ＜ 4, in 
individual patients who changed their diagnosis from functional 
heartburn to non-erosive reflux disease during prolonged wireless pH 
monitoring. The horizontal line represents the upper limit of normal 
range.
Table 1. Acid Exposure Time, Expressed as % Time at pH ＜ 4, in
Functional Heartburn and Non-erosive Reflux Disease Patients
FH Day 1 (35) Day 2 (35) Day 3 (17) Day 4 (8)
Total 0.9; 0.5-2.8 1.6; 0.6-4.1 1.4; 0.3-2.4 0.9; 0.3-1.4
NERD Day 1 (15) Day 2 (15) Day 3 (10) Day 4 (7)
  Total 2; 1.3-2.6 6.1; 3.5-8.9b 4.2; 2.7-6.1b 6.1; 4-9.8b
  Uprighta 2.9; 1.8-3.5 6.9; 3.2-8.8 5.9; 2.9-10.7 7.2; 4.4-12.4
  Supinea 0; 0-0.3 0.2; 0-9.4 0.3; 0.1-1.5 2.9; 1.3-13.7
aData available only for 13 patients; bP ＜ 0.01 vs FH patients.
FH, functional heartburn; NERD, non-erosive reflux disease.
Data are expressed as median (interquartile range [IQR]). Number of patients 
in brackets.
confirmed. In particular, the number of patients with FH dimin-
ished from 50 to 40 after 48 hours, to 38 after 72 hours, and to 35 
after 96 hours. Within the patients with change in diagnosis, one 
had an AET ＞ 5% in all three days, 1 in 2 consecutive days and 
all the other 13 patients had a single-day pathological AET. AET 
over the 4 days in NERD patients is described in Figure.
Symptom reflux association
Twenty-three out of 50 patients experienced three or more 
episodes of heartburn during at least one day of monitoring. In 
one patient only SI for heartburn became positive after the first 
day of recording, changing the diagnosis to NERD, but this had 
no added value after the AET analysis, as it occurred together 
with pathological AET. 
No patients had a positive SI for acid regurgitation or chest 
pain during the first 24 hours. Only one patient reported a pos-
itive SI for regurgitation during the second and the third day of 
monitoring, suggesting the diagnosis of NERD. 
Calculation of a cumulative SI for all 3 symptoms together 
proved to be of no additional benefit since it was positive only in 
one patient, the same one with positive SI for acid regurgitation.
Characteristics of Functional Heartburn 
Versus Non-erosive Reflux Disease 
Proton pump inhibitor refractoriness
All patients were refractory to a PPI treatment of at least 12 
weeks. In the FH group we were able to collect the information 
on the PPI dose pre pH test in 28 patients and 18 of them (64%) 
underwent a double dose. In the NERD group the information 
was collected in 10 patients and 7 (70%) underwent a double dose 
(P = 0.743 vs FH). In the FH group we retrieved the in-
formation of partial or no response to PPIs in 29 patients and 18 
(62%) had a partial response. In the NERD group the in-
formation was retrieved in 13 patients and 12 (92%) had a partial 
response (P ＜ 0.05 vs FH).
pH monitoring and clinical features
AET description of the 2 groups is detailed in Table 1. AET 
was not different between FH and NERD patients in the first 
day, whereas it was so in the remaining three days (P ＜ 0.01). 
Considering daily differences within each group, in the 8 FH and 
in the 7 NERD patients having 96 hours of recordings, AET 
was higher in day 2 compared to day 4 in FH (P ＜ 0.05) where-
as it was higher in day 4 compared to day 1 in NERD (P ＜ 
0.05). 
Upright and supine values were not available for 2 of the 15 
NERD patients. Considering the days with pathological 24-hour 
AET, 3 out of the remaining 13 patients showed pathological 
AET both in upright and supine periods, whereas 7 patients had 
increased upright esophageal acid exposure and normal supine 
AET (10.7 [7.5-13.8] and 0 [0-0.2]); isolated pathological su-
pine AET was seen in the remaining 3 patients. 
Number of HB episodes in the first day were not different 
between FH and NERD (Table 2) and so was during the whole 
monitoring, 3 (0-6) vs 4 (1-12). Moreover, within each group, 
frequency of heartburn was similar in the 4 days of monitoring 
(Table 2).
Similarly to HB, no differences were seen between FH and 
NERD in occurrence of regurgitation or chest pain over the 
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Table 2. Number of Symptomatic Episodes in Functional Heart-
burn and Non-erosive Reflux Disease Patients
Heartburn Regurgitation Chest pain
FH (35)
  Day 1 1 (0-4) 0 (0-2) 0 (0-2)
  Day 2 1 (0-4) 0 (0-2) 0 (0-2)
  Day 3 0 (0-5) 0 (0-2) 0 (0-3)
  Day 4 0 (0-1) 0 (0-0) 0 (0-2)
NERD (15)
  Day 1 1 (0-4) 0 (0-0) 0 (0-1)
  Day 2 1 (0-4) 0 (0-2) 0 (0-0)
  Day 3 1 (0-4) 1 (0-7) 0 (0-1)
  Day 4 1 (0-4) 0 (0-3) 0 (0-1)
FH, function.
Data are expressed as median (interquartile range [IQR]). Number of patients 
in brackets.
whole monitoring, 0 (0-5) vs 0 (0-6) and 0 (0-4) vs 0 (0-3) re-
spectively; no differences were also observed among individual 
days within each group of patients (Table 2).
There was a trend toward a younger age in the 35 FH versus 
the 15 patients who changed their diagnosis to NERD, (45 
[38-55] years vs 55 [46-59] years; P = 0.086), whereas gender 
composition (female, 77% vs 80%; P = 0.823) and BMI (24.8 
vs 25.5, P = 0.185) did not differ. Information on functional 
gastrointestinal disorders or psychological diseases was not re-
corded systematically and therefore has not been analyzed.
Outcome
Seven patients were lost to follow-up in the FH group and 2 
in the NERD group. Antireflux surgery was performed in 2 FH 
and 3 NERD, all of whom had partial response to double dose 
PPIs, 1 FH, and all 3 NERD had a positive outcome. Overall 
22/28 (79%) FH and all of the 13 NERD patients were on PPIs 
or underwent antireflux surgery. However only 3/28 (11%) FH 
took a higher PPI dose compared to the pre pH test or under-
went antireflux surgery versus 7/13 (54%) of NERD patients (P 
＜ 0.003).
A positive outcome, ie, heartburn better or absent, was pres-
ent in 12/28 (43%) of the whole FH group and 10/22 (45%) of 
those FH patients who were on PPIs or underwent antireflux 
surgery versus 10/13 (77%) of NERD patients (P ＜ 0.05 and P 
= 0.069 vs all FH and FH on GERD treatment, respectively).
Discussion
Our main findings were that one third of endoscopy negative 
heartburn patients refractory to PPIs, diagnosed as FH during 
the first 24 hours of pH monitoring were actually patients with 
GERD as detected during a more prolonged pH recording. This 
observation, which underlies limitations of 24-hour pH studies, 
should be is clinically relevant because, whereas the diagnosis of 
FH should induce the physician to stop prescribing unnecessary 
PPI treatment, the diagnosis of GERD related heartburn should 
both support a trial of high dose prolonged pharmacological 
treatment of GERD and open to the therapeutic option of antire-
flux surgery. 
As a matter of fact outcome data, obtained in the majority of 
patients, showed that physicians increased the dose of PPIs or in-
dicated antireflux surgery more frequently in our NERD than in 
our FH patients. However, they also showed that physicians of-
ten do not pay attention to a negative pH study continuing to pre-
scribe PPIs and even sending their patients to antireflux surgery, 
as already observed in our previous study.28 
Furthermore our findings suggest that previous studies look-
ing at morphological and/or pathophysiological differences be-
tween FH and NERD, diagnosed with 24-hour pH/pH-im-
pedance studies,10-14 may have been inaccurate. Structural char-
acteristics, which are devoid of day to day fluctuations, ie, histo-
pathological parameters or basal impedance, could be the best 
variables in order to diagnose FH, but their diagnostic perform-
ance needs to be evaluated against a gold standard. 48-96 hours 
pH monitoring could serve for this purpose. AET is known to 
vary from day to day,15-17 thus opening to the possibility of a false 
negative result for GERD. Prolonging pH monitoring to 48 
hours allowed us to detect 10 patients with pathological AET and 
further prolonging the test to 96 hours allowed to detect 5 more 
patients, in line with previous data showing that 96 hours is better 
than 48 hours in the diagnosis of GERD.28-30 AET was the most 
important variable in order to diagnose GERD after the first 24 
hours of pH monitoring. In one patient only the heartburn/reflux 
association changed from negative to positive in the second day of 
recording and it was accompanied by pathological AET.
We also looked at the possibility that inclusion of other symp-
toms, such as regurgitation or chest pain, in the calculation of 
symptom/reflux association increases the power of symptom/re-
flux association indexes for exclusion of FH. However, it was not 
the case because regurgitation and chest pain were quite in-
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frequent in this patients’ population and, in one patient only, ad-
dition of regurgitation has suggested to exclude the diagnosis of 
FH.
When looking at the distribution of acid reflux in the 24 
hours in our patients with pathological AET, 76% had increased 
reflux during daytime in line with the evidence that NERD pa-
tients are mainly postprandial upright refluxers.33
It could be argued that during the day of capsule positioning 
patients may have eaten and moved less than during the following 
days because of the discomfort of the endoscopy and sedation. 
We do not think this to be the case for several reasons. First, the 
literature looking at trends of AET during the days of prolonged 
pH monitoring has generally reported similar AETs,21,23,26,27,34 
more rarely higher35,36 or lower37,38 AET in the first day of re-
cording compared to the others. As a matter of fact our data have 
shown that AET in day 2 was not significantly higher than AET 
in day 1 both in patients with normal and in those with patho-
logical reflux. Furthermore 13 out of the 15 patients who were di-
agnosed as NERD had pathological AET during one of the days 
only. Finally, the mild i.v. sedation we used is known to allow al-
most full psychomotor recovery 30 minutes after upper endoscopy.39 
Another information we looked for in our 50 patients was a 
difference in demographics, clinical presentation, characteristics 
of reflux or symptoms during the first 24 hours of pH monitor-
ing between those that remained FH and those who were diag-
nosed as NERD. We could not find any significant differences 
although numbers were relatively small. The retrospective nature 
of our study did not allow us to collect information on presence of 
comorbidities, such as functional gastrointestinal disorders, in a 
sufficient number of patients or whether the first day of recording 
was different from everyday life concerning the symptom profile. 
Our technique devoid of impedance monitoring could not 
differentiate patients with heartburn related to weakly acidic re-
flux, who are erroneously diagnosed as FH during 24 hours pH 
monitoring, as shown by a big series of endoscopy negative pa-
tients with typical GERD symptoms.9 We do not know if these 
patients partially overlap with those showing pathological AET 
after the first day of wireless pH monitoring and also if 48 hours 
catheter based pH/impedance monitoring is feasible and im-
proves the diagnosis of GERD. Further studies could answer 
these questions.
Results on outcome should be cautiously considered due to 
the retrospective nature of our study. Nevertheless it showed a 
positive impact of the pH test on management and outcome of 
patients classified as NERD. Not all of the NERD patients, 
however, had satisfactory outcome, although they were all on an-
tireflux treatment. We cannot exclude that our pH test was falsely 
positive. Presence of GERD was assessed with the “worst day” 
analysis which is more sensitive than the “whole period analysis,” 
but it is presumably less specific.40 Regarding patients with FH, 
it might seem weird that 45% of them had a positive outcome, but 
reassurance after a negative diagnostic test, ie, upper gastro-
intestinal endoscopy, has already been shown to diminish anxiety, 
improve quality of life and decrease consultations in patients with 
dyspepsia.41,42 Furthermore, placebo effect of drugs is frequent in 
functional disorders.43 As a final consideration, we need to point 
out that our paper relates to a “real world” situation, involving 
those patients that are referred to our three Centers for wireless 
pH monitoring, and not to a clinical trial. Compliance to treat-
ment was not recorded and in one-third of our patients refractori-
ness was based in a standard dose PPI. It is thus possible that 
some of our patients were PPI responders at higher doses,44,45 as 
suggested by our follow up data and that wireless pH monitoring 
was not indicated. Nevertheless in this “real world” scenario wire-
less pH monitoring was useful for patients’ management. A pro-
spective study with a bigger cohort of patients is warranted. 
In conclusion, our data underlie the moderate reliability of 24 
hours reflux studies in the diagnosis of FH. They suggest useful-
ness of prolonged wireless pH monitoring in selected cases of 
clinical practice where there is a strong clinical suspicion of 
GERD, but normal 24 hours reflux monitoring.
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